The National Breast & Cervical Cancer Early Detection Program
For 30 years, the Centers for Disease Control and Prevention’s National Breast and Cervical Cancer Early Detection Program has decreased disparities in breast and cervical cancer deaths.
ACS CAN Comments on Draft FDA Guidance on Clinical Trial Diversity Plans
June 13, 2022
ACS CAN submitted comments to the U.S. Food and Drug Administration (FDA) on the Diversity Plans To Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials Draft Guidance for Industry.